Authors
Loading...
Engineered CAR-T cells show anti-tumor efficacy in humanized mouse models, highlighting resistance to immunological barriers.
Stephen Matthew Hatfield (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: